Skip to main content
OpenTrials

Clinical trial condition

Fanconi Anemia, Complementation Group D1

Explore clinical trials studying Fanconi Anemia, Complementation Group D1. Study availability and eligibility vary by location and protocol.

25 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Fanconi Anemia, Complementation Group D1 trial results

Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

NCT06458712

Conditions
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency), Anophthalmia with pulmonary hypoplasia, Fanconi Anemia, Complementation Group D1, +1 more
Locations
  • Yale Cancer Center - Yale New Haven Hospital New Haven, Connecticut, United States
  • Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Institut Bergonie Bordeaux, France
View all 18 locations
View Trial Details
Recruiting

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

NCT04038502

Conditions
BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
Locations
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States
  • Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora, Colorado, United States
  • Washington DC VA Medical Center, Washington, DC Washington D.C., District of Columbia, United States
  • Bay Pines VA Healthcare System, Pay Pines, FL Bay Pines, Florida, United States
View all 18 locations
View Trial Details
Completed

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

NCT00753545

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Research Site Berkeley, California, United States
  • Research Site San Francisco, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Sunrise, Florida, United States
View all 107 locations
View Trial Details
Completed

Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer

NCT00494234

Conditions
Breast Diseases, Breast Neoplasms, Fanconi Anemia, Complementation Group D1, +4 more
Locations
  • Research Site West Hollywood, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Melbourne, Australia
  • Research Site Randwick, Australia
View all 17 locations
View Trial Details
Completed

C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population

NCT02503436

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations
  • Research Site Amberg, Germany
  • Research Site Aschaffenburg, Germany
  • Research Site Augsburg, Germany
  • Research Site Bad Homburg, Germany
View all 68 locations
View Trial Details
Completed

Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma

NCT02039388

Conditions
Adnexal Diseases, Carcinoma, Carcinoma in Situ, +20 more
Locations
  • Medical University Graz - Universitätsklinik f. Frauenheilkunde u. Geburtshilfe Graz, Austria
  • Kepler University Linz Linz, Austria
  • Medical University Vienna, Dptm. of Obstetrics & Gynaecology Vienna, Austria
  • Catholic University Leuven - Department of Obstetrics and Gynaecology Leuven, Belgium
View all 14 locations
View Trial Details
Completed

Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

NCT04425200

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi Anemia, Complementation Group D1, +19 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
View all 26 locations
View Trial Details

Related conditions